Observatoire Régional Breton sur l’Infarctus (ORBI) Risk Score
Stratifies risk of in-hospital cardiogenic shock in patients undergoing primary percutaneous coronary intervention (PCI).
Name Alert!
This tool assesses cardiogenic shock risk. It is not related to ORBIT, which estimates bleeding risk in anticoagulated patients with atrial fibrillation.
Advice
- A low score does not rule out subsequent cardiogenic shock and should not replace clinical assessment; continue post-PCI monitoring per institutional protocols and escalate care promptly if signs of shock develop.
- This tool does not predict all post-STEMI cardiovascular risks, including mortality, and should not replace other early risk stratification tools (e.g., TIMI, GRACE).
Management
- Lower-risk individuals:
- May be suitable for routine post-PCI monitoring per institutional protocols.
- Reassess if clinical status changes.
- Higher-risk individuals:
- Plan for a higher level of care (ICU versus stepdown) post-PCI.
- Institute more frequent hemodynamic and urine output monitoring.
- Consider deferring or using caution with early initiation of therapies that may worsen hemodynamics in borderline patients (e.g., beta-blockers, ACE/ARBs), based on the overall clinical picture and local practice.
- Engage the institutional “shock team” and consult advanced heart failure specialists early.
- Establish an early plan for clinical deterioration, ensuring rapid access to vasopressor and inotropic support and mechanical circulatory support pathways.